Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study
- Conditions
- Obsessive Compulsive Disorder (OCD)
- Interventions
- Device: Transcranial magnetic stimulationBehavioral: Cognitive behavioral therapy
- Registration Number
- NCT02528331
- Lead Sponsor
- Duke University
- Brief Summary
The purpose of this study is to evaluate the effectiveness of repetitive TMS (rTMS) delivered simultaneously with elements of cognitive behavioral therapy/exposure-response prevention (CBT/ERP) in adult subjects (greater or equal to 18 years old) with obsessive-compulsive disorder (OCD). This is an open label study that involves standard of care for OCD (CBT) and an investigational treatment modality (TMS). The investigators will compare the Yale-Brown Obsessive Compulsive Scale (YBOCS) scores before and after treatment to quantify clinical improvement. The side effects from TMS include, but are not limited to, headache, seizure, and general pain. CBT has minimal side effects other than mental discomfort during the exposure sessions. For safety concerns, pregnant women and subjects with seizure-related history will be excluded as well as other indicated conditions in the details protocol.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 2
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description rTMS and Cognitive Behavior Therapy Cognitive behavioral therapy - rTMS and Cognitive Behavior Therapy Transcranial magnetic stimulation -
- Primary Outcome Measures
Name Time Method Remission Rate, as Measured by Y-BOCS 6 weeks Remission is defined as end-point Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score less than the value of 16.
- Secondary Outcome Measures
Name Time Method Percentage of Adverse Events 6 weeks Partial Response Rate, as Measured by Y-BOCS 6 weeks Partial response is defined as a reduction of greater than 25%.
Complete Response, as Measured by Y-BOCS 6 weeks Complete response is defined as a reduction of Y-BOCS score greater than 35%.
Trial Locations
- Locations (1)
Duke University Medical Center
🇺🇸Durham, North Carolina, United States